News
Long-term extension data presented at the Alzheimer's Association International Conference showed amyloid plaque ...
Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences ...
A new report found that 85% of pharma respondents are increasing their artificial intelligence investments, and 70% see AI as an immediate priority. Two experts discuss how biopharmas are implementing ...
George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...
As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more ...
Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...
Monarez is the first CDC director to be confirmed by the Senate under a new 2023 law and will be the first person without a ...
CEO Emma Walmsley maintained that continued investment in the U.S. is a priority for the pharma to ensure its medicines for ...
In a surprise double announcement Tuesday, Novo reduced sales guidance by 5%—attributing the change to slowed growth of its ...
Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...
The FDA’s dramatic summer continues to unfold as news broke late Tuesday evening that Vinay Prasad will depart the agency, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results